DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
-7.48%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$2.45B
AUM Growth
+$2.45B
(-12%)
Cap. Flow
-$57.8M
Cap. Flow
% of AUM
-2.36%
Top 10 Holdings %
Top 10 Hldgs %
44.05%
Holding
113
New
16
Increased
20
Reduced
24
Closed
16
Top Buys
| 1 |
Rhythm Pharmaceuticals
RYTM
|
$42.4M |
| 2 |
Mirum Pharmaceuticals
MIRM
|
$34.7M |
| 3 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$29.5M |
| 4 |
SWTX
SpringWorks Therapeutics
SWTX
|
$22.8M |
| 5 |
Centene
CNC
|
$18.1M |
Top Sells
| 1 |
Natera
NTRA
|
$27.7M |
| 2 |
STAAR Surgical
STAA
|
$25.8M |
| 3 |
NVRO
NEVRO CORP.
NVRO
|
$25M |
| 4 |
IMMU
Immunomedics Inc
IMMU
|
$23.5M |
| 5 |
NVTA
Invitae Corporation
NVTA
|
$23.4M |
Sector Composition
| 1 | Healthcare | 71.32% |
| 2 | Financials | 0.3% |
| 3 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
HZNP
1
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $176M | 7.17% | 6,462,634 | – | – |
|
2
Viatris
VTRS
$12.3B
| $151M | 6.17% | 7,654,065 +189,738 | +3% | +$3.75M |
|
|
ORTX
3
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $106M | 4.32% | 8,923,600 | – | – |
|
4
Q32 Bio
QTTB
$20.9M
| $104M | 4.25% | 5,760,368 | – | – |
|
|
AERI
5
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $87.8M | 3.58% | 4,568,824 +1,535,837 | +51% | +$29.5M |
|
|
6
Rhythm Pharmaceuticals
RYTM
$6.85B
| $55.9M | 2.28% | 2,589,291 +1,965,358 | +315% | +$42.4M |
|
7
Brookdale Senior Living
BKD
$1.83B
| $54.6M | 2.23% | 7,207,239 | – | – |
|
|
XENT
8
DELISTED
Intersect ENT, Inc
XENT
| $52.9M | 2.16% | 3,109,004 | – | – |
|
|
XLRN
9
DELISTED
Acceleron Pharma Inc.
XLRN
| $51.6M | 2.1% | 1,305,174 | – | – |
|
|
MYOK
10
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $51.2M | 2.09% | 981,430 -15,570 | -2% | -$812K |
|
|
IMMU
11
DELISTED
Immunomedics Inc
IMMU
| $42.6M | 1.74% | 3,214,000 -1,771,383 | -36% | -$23.5M |
|
|
RARX
12
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $40.9M | 1.67% | 1,728,019 +15,019 | +0.9% | +$355K |
|
|
13
Mirum Pharmaceuticals
MIRM
$3.71B
| $34.7M | 1.41% | +3,448,912 | New | +$34.7M |
|
14
argenx
ARGX
$43.6B
| $32M | 1.31% | 281,000 | – | – |
|
|
SILK
15
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $31.9M | 1.3% | 979,480 +480,450 | +96% | +$15.6M |
|
16
Vericel Corp
VCEL
$1.83B
| $31.5M | 1.28% | 2,081,000 +11,399 | +0.6% | +$173K |
|
17
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $31.2M | 1.27% | 1,540,305 -137,717 | -8% | -$2.79M |
|
|
18
Centene
CNC
$14.3B
| $31.2M | 1.27% | 720,400 +417,400 | +138% | +$18.1M |
|
19
Fate Therapeutics
FATE
$120M
| $30.3M | 1.24% | 1,952,897 +250,000 | +15% | +$3.88M |
|
20
Alector
ALEC
$238M
| $29.9M | 1.22% | 2,076,812 +329,889 | +19% | +$4.76M |
|
21
Sarepta Therapeutics
SRPT
$1.78B
| $28.8M | 1.17% | 382,000 +72,975 | +24% | +$5.5M |
|
22
Select Medical
SEM
$1.61B
| $28.4M | 1.16% | 1,714,099 -329,428 | -16% | -$5.46M |
|
|
BPMC
23
DELISTED
Blueprint Medicines
BPMC
| $27.7M | 1.13% | 377,200 -14,054 | -4% | -$1.03M |
|
|
DBVT
24
DBV Technologies
DBVT
$264M
| $27.5M | 1.12% | 3,201,222 | – | – |
|
|
SIEN
25
DELISTED
Sientra, Inc.
SIEN
| $26.8M | 1.09% | 4,137,470 -514,836 | -11% | -$3.34M |
|